Welcome!

News Feed Item

/ CORRECTION - Classic Textbook on Critical Care, the ICU book by Paul Marino, M.D., PhD., Recommends Direct Measurement of Blood Volume in Evaluating Critically Ill Patients

The reason for this restated press release is that there was a single statistical error contained in this morning's press release which has been corrected

NEW YORK, NY -- (Marketwired) -- 01/07/14 -- In the news release, "Classic Textbook on Critical Care, the ICU book by Paul Marino, M.D., PhD., Recommends Direct Measurement of Blood Volume in Evaluating Critically Ill Patients," issued earlier today by Daxor Corporation (NYSE MKT: DXR), we are advised by the company that the last sentence of the second paragraph should read "8% death rate vs. a 24% death rate" rather than "8% survival rate vs. a 20% death rate" as originally issued. Complete corrected text follows.

Classic Textbook on Critical Care, the ICU book by Paul Marino, M.D., PhD., Recommends Direct Measurement of Blood Volume in Evaluating Critically Ill Patients

NEW YORK, NY -- January 7, 2014 -- Daxor Corporation (NYSE MKT: DXR)

The most widely read textbook in critical care medicine is the ICU book (intensive care unit) by Paul Marino, M.D. The fourth edition of this book has just been published by Lippincott Williams & Wilkins, and has important information about blood volume measurement. Dr. Marino, who is on the staff of Cornell Medical School, is an internationally recognized authority on critical care medicine.

The previous third edition was published in 2007. The fourth edition has important new information about the use of blood volume measurement. In a chapter on hypovolemia (low blood volume) Dr. Marino writes "Blood volume measurements have traditionally required too much time to perform to be clinically useful in an ICU setting, but this has changed with the introduction of a semi-automated blood volume analyzer (Daxor Corporation, New York, NY) that provides blood volume measurements in less than an hour. Blinded measurements of blood, red cell, and plasma volumes were performed in patients with circulatory shock who were managed with pulmonary artery catheters, and the results show that blood and plasma volumes were considerably higher than normal. When blood volume measurements were made available for patient care, 53% of the measurements led to a change in fluid management, and this was associated with a significant decrease in mortality rate (from 24% to 8%). These results will require corroboration, but they highlight the limitations of the clinical assessment of blood volume, and the potential for improved outcomes when blood volume measurements are utilized for fluid management." Dr. Marino's book cited a study by Dr. Mihae Yu and included a graph of her research which was published in Shock (A Prospective Randomized Trial Using Blood Volume Analysis in Addition to Pulmonary Artery Catheter, Compared with Pulmonary Artery Catheter Alone, to Guide Shock Resuscitation in Critically Ill Surgical Patients; Shock, Vo. 35, No. 3, pp 220-228, 2011). This landmark study by Dr. Yu studied 100 critically ill patients in the ICU. 50 of them were treated on the basis of a blood volume measurement plus PAC, and 50 were treated on the basis of PAC without knowledge of the blood volume measurement. The patients who were treated on the basis of a blood volume measurement had an 8% death rate vs. a 24% death rate in the patients who were treated without knowledge of the blood volume measurement.

The most common laboratory tests to evaluate a patient's blood volume are the hematocrit and hemoglobin tests. These tests only measure the concentration of red blood cells, not the volume of the patient's blood. Dr. Marino's book contains the following statement "The use of the hematocrit (and hemoglobin concentration) to evaluate the presence and severity of acute blood loss is both common and inappropriate. Changes in hematocrit show a poor correlation with blood volume deficits and erythrocyte deficits in acute hemorrhage. Acute blood loss involves the loss of whole blood, which results in proportional decreases in the volume of plasma and erythrocytes. As a result, acute blood loss results in a decrease in blood volume but not a decrease in hematocrit. (There is a small dilutional effect from transcapillary refill in acute blood loss, but this is usually not enough to cause a significant decrease in hematocrit.) In the absence of volume resuscitation, the hematocrit will eventually decrease because hypovolemia activates the rennin-angiotensin-aldosterone system, and the renal retention of sodium and water that follows will have a dilutional effect on the hematocrit. This process begins 8 to 12 hours after acute blood loss, and can take a few days to become fully established." That statement is based on original research by Drs. S. Oohashi and H. Endoh, who examined physicians' assessments of patients' blood volumes with actual blood volume measurements and found them to be extremely disparate. Previously, studies from Columbia Presbyterian Medical Center also demonstrated that physicians treating heart failure patients were only correct 51% of the time using the usual clinical parameters and laboratory tests in evaluating the blood volume status of a patient.

Dr. Marino's chapter focused particularly on the detection of hypovolemia (low blood volume). He cited studies which used invasive procedures such as pulmonary artery catheterization (PAC) and central venous pressure to assess a patient's blood volume. Previous studies have demonstrated, in situations where blood volume measurements were actually made, that such assessments are frequently wrong.

Dr. Feldschuh, the president of Daxor, a board certified cardiologist, noted that it is truly tragic that the overwhelming majority of patients treated in intensive care units are not treated based on actual blood volume measurements. Instead, they are treated on the basis of inaccurate tests such as hematocrits and hemoglobins, and invasive procedures such as pulmonary artery catheterization, which multiple studies have shown to be inaccurate for evaluating a patient's blood volume.

Dr. Feldschuh stated that it is unfortunate that thousands of patients die every year because they are not treated correctly due to inaccurate assessments of blood volume. These tests only measure the concentration of red blood cells in a patient, they do not measure a patient's total blood volume. The BVA-100 can measure blood volume to an accuracy of 98%.

Dr. Marino closed this particular chapter with the following comments: "The clinical evaluation of intravascular volume, including the use of central venous pressure (CVP) measurements, is so flawed it has been called a 'comedy of errors'" and "Direct measurements of blood volume are clinically feasible, but are underutilized."

The past week extensive publicity was given to the case of a 13 year old girl in California who had a tonsillectomy and was said to have bled extensively. Unfortunately her blood loss was not properly replaced and she was pronounced brain dead. This is the type of case that occurs by the thousands every year. In addition to patients who die from inadequate treatment, thousands more suffer heart attacks and strokes. Many patients with lack of brain oxygen ultimately develop dementia. Lack of oxygen to the brain is well known to destroy and irreversibly damage brain cells. The knowledge of how to perform accurate blood volume measurement has been known for more than 70 years. An automated blood volume measurement instrument has been available for more than 10 years. The excuse for not performing blood volume measurement has always been that the test is too difficult to perform accurately and takes 4 to 8 hours. The BVA-100 has automated most of the procedure and enables the blood volume measurement to be done in under an hour. Inability to obtain rapid blood volume measurements should no longer be an excuse for treating critically ill patients with blood volume derangements on the basis of tests which are known to be inaccurate and may result in irreversible damage and even death to patients.

Dr. Feldschuh will be attending the annual meeting of Critical Care Medicine in San Francisco January 8 - 13, 2014. This is the main annual meeting of physicians specializing in intensive care unit medicine.

Contact Information:
Daxor Corporation:
Diane Meegan
212-330-8512
(Investor Relations)
[email protected]

Richard Dunn
212-330-8502
(Director of Operations)
[email protected]

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
No hype cycles or predictions of zillions of things here. IoT is big. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, Associate Partner at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He discussed the evaluation of communication standards and IoT messaging protocols, data analytics considerations, edge-to-cloud tec...
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settl...
In his session at @ThingsExpo, Dr. Robert Cohen, an economist and senior fellow at the Economic Strategy Institute, presented the findings of a series of six detailed case studies of how large corporations are implementing IoT. The session explored how IoT has improved their economic performance, had major impacts on business models and resulted in impressive ROIs. The companies covered span manufacturing and services firms. He also explored servicification, how manufacturing firms shift from se...
IoT is at the core or many Digital Transformation initiatives with the goal of re-inventing a company's business model. We all agree that collecting relevant IoT data will result in massive amounts of data needing to be stored. However, with the rapid development of IoT devices and ongoing business model transformation, we are not able to predict the volume and growth of IoT data. And with the lack of IoT history, traditional methods of IT and infrastructure planning based on the past do not app...
For far too long technology teams have lived in siloes. Not only physical siloes, but cultural siloes pushed by competing objectives. This includes informational siloes where business users require one set of data and tech teams require different data. DevOps intends to bridge these gaps to make tech driven operations more aligned and efficient.
For organizations that have amassed large sums of software complexity, taking a microservices approach is the first step toward DevOps and continuous improvement / development. Integrating system-level analysis with microservices makes it easier to change and add functionality to applications at any time without the increase of risk. Before you start big transformation projects or a cloud migration, make sure these changes won’t take down your entire organization.
It is ironic, but perhaps not unexpected, that many organizations who want the benefits of using an Agile approach to deliver software use a waterfall approach to adopting Agile practices: they form plans, they set milestones, and they measure progress by how many teams they have engaged. Old habits die hard, but like most waterfall software projects, most waterfall-style Agile adoption efforts fail to produce the results desired. The problem is that to get the results they want, they have to ch...
Organizations planning enterprise data center consolidation and modernization projects are faced with a challenging, costly reality. Requirements to deploy modern, cloud-native applications simultaneously with traditional client/server applications are almost impossible to achieve with hardware-centric enterprise infrastructure. Compute and network infrastructure are fast moving down a software-defined path, but storage has been a laggard. Until now.
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service.
Digital Transformation is much more than a buzzword. The radical shift to digital mechanisms for almost every process is evident across all industries and verticals. This is often especially true in financial services, where the legacy environment is many times unable to keep up with the rapidly shifting demands of the consumer. The constant pressure to provide complete, omnichannel delivery of customer-facing solutions to meet both regulatory and customer demands is putting enormous pressure on...
The best way to leverage your CloudEXPO | DXWorldEXPO presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering CloudEXPO | DXWorldEXPO will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at CloudEXPO. Product announcements during our show provide your company with the most reach through our targeted audienc...
DXWorldEXPO LLC announced today that All in Mobile, a mobile app development company from Poland, will exhibit at the 22nd International CloudEXPO | DXWorldEXPO. All In Mobile is a mobile app development company from Poland. Since 2014, they maintain passion for developing mobile applications for enterprises and startups worldwide.
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors!
JETRO showcased Japan Digital Transformation Pavilion at SYS-CON's 21st International Cloud Expo® at the Santa Clara Convention Center in Santa Clara, CA. The Japan External Trade Organization (JETRO) is a non-profit organization that provides business support services to companies expanding to Japan. With the support of JETRO's dedicated staff, clients can incorporate their business; receive visa, immigration, and HR support; find dedicated office space; identify local government subsidies; get...
"Akvelon is a software development company and we also provide consultancy services to folks who are looking to scale or accelerate their engineering roadmaps," explained Jeremiah Mothersell, Marketing Manager at Akvelon, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.